According to a new comprehensive report from The Insight Partners, the global Omni-Directional Antenna market is ...
said James (Jim) Frakes, CEO and CFO of Aethlon Medical. In the initial three patients, there were encouraging changes in ...
MicroRNAs: Following a single 4-hour HP treatment, decreases were observed in seven out of ten miRNAs examined in two of the three participants. MicroRNAs are one component of the cargo of ...
Recent clinical trial update news from Aethlon Medical, Inc. ( Nasdaq: AEMD ), Envoy Medical, Inc. ( Nasdaq: COCH ), ...
In 4 completed studies and the ongoing OL study, 65 participants received at least 1 dose of nomlabofusp, including 39 in the OL study, with 14 ...
The excessive and uncontrolled consumption of alcohol, which can culminate in the development of alcohol use disorder or ...
Recent clinical trial update news from Aethlon Medical, Inc. (NASDAQ: AEMD), Envoy Medical, Inc. (NASDAQ: COCH), Soligenix, ...
"In the years since COVID, employees have been more engaged with their benefits than ever before. People are going back to ...
Tiffany Nassiri-Ansari and colleagues set out how a decolonial feminist approach to innovation could produce greater gender ...
Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced today a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback